Chadstone, Australia

Ashley J Knights

This inventor holds 1 USPTO granted patent. Top assignee: California Institute of Technology. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashley J Knights. Retrieved from https://idiyas.com/inventor/ashley-j-knights

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ashley J Knights

Introduction

Ashley J Knights is an accomplished inventor based in Chadstone, Australia. She has made significant contributions to the field of immunology, particularly in the development of T cell receptors. Her work is vital for advancing cancer therapies and understanding immune responses.

Latest Patents

Ashley holds a patent titled "Composition of NY-ESO-1-Specific T Cell Receptors Restricted on Multiple Major Histocompatibility Complex Molecules." This patent represents her innovative approach to enhancing T cell receptor specificity, which is crucial for targeted cancer treatments. She has 1 patent to her name, showcasing her dedication to advancing medical science.

Career Highlights

Ashley is affiliated with the California Institute of Technology, where she collaborates with leading researchers in her field. Her work at this prestigious institution has allowed her to explore groundbreaking ideas and contribute to significant advancements in immunotherapy.

Collaborations

Throughout her career, Ashley has worked alongside notable colleagues, including Jami McLaughlin Witte and Antoni Ribas. These collaborations have enriched her research and expanded the impact of her innovations in the scientific community.

Conclusion

Ashley J Knights exemplifies the spirit of innovation in the field of immunology. Her contributions, particularly in T cell receptor development, are paving the way for future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…